Co-Founders and Management Team
Ben is the founder and CEO of Spin Up Science Ltd, an organisation that works to create frontier science ventures based on university IP by empowering and upskilling scientists and engineers in entrepreneurship and innovation. Spin Up Science operates across 6 cities in the UK aims to establish the UK as a world-leader in innovation activity. Through Spin Up Science, Ben has worked as a catalyst of innovation activity supporting over 100 early-stage scientific ventures. Ben completed his PhD at the University of Bristol in Nanophysics and Optics.
SAS Expertise: Physics, Nanomaterials, Electronics, Imaging, Sensing, Quantum, Diagnostics
Johnathan is an active angel investor with a portfolio of 38 frontier science and technology companies. Johnathan is a NED and board observer for several companies in his portfolio including Argonaute RNA, Glaia, Genome Key and Anaphite. He is an advisor for Elbow Beach Capital and Ascension Ventures Life Fund. Johnathan is co-founder of Science Angel Syndicate, founded in 2021 with a mission to source world-class scientific discoveries, provide unique scientific due diligence and help investors to identify exceptional investment opportunities. Johnathan holds a PhD from the University of Bristol in Organic Chemistry and is a Chartered Chemist of the Royal Society of Chemistry. Johnathan was part of the science team who patented (WO/2018/167503) a platform technology that could unlock the ability to create the world’s first glucose responsive insulin. The commercial journey was realised through University of Bristol spin-out Ziylo, which was acquired in August 2018 by Novo Nordisk A/S in a staged M&A for up to £623m.
SAS Expertise: Chemistry, Biotech, Advanced Materials, HealthTech, MedTech